These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles. Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389 [TBL] [Abstract][Full Text] [Related]
29. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen. Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388 [TBL] [Abstract][Full Text] [Related]
31. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Birlik B; Canda S; Ozer E Neuropathol Appl Neurobiol; 2006 Oct; 32(5):532-8. PubMed ID: 16972887 [TBL] [Abstract][Full Text] [Related]
32. Expression of diagnostic neuronal markers and outcome in glioblastoma. Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476 [TBL] [Abstract][Full Text] [Related]
33. T cell adoptive immunotherapy of newly diagnosed gliomas. Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070 [TBL] [Abstract][Full Text] [Related]
34. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas. Hoshino T J Neurosurg; 1984 Nov; 61(5):895-900. PubMed ID: 6491735 [TBL] [Abstract][Full Text] [Related]
35. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
36. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844 [TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy. Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493 [TBL] [Abstract][Full Text] [Related]
38. Prognostic role of urokinase-type plasminogen activator in human gliomas. Hsu DW; Efird JT; Hedley-Whyte ET Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873 [TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063 [TBL] [Abstract][Full Text] [Related]
40. Proliferative activity of chosen central nervous system (CNS) neoplasms. Lebelt A; Szkudlarek M; Guzińska-Ustymowicz K; Lemancewicz D; Zimnoch L; Dziecioł J Rocz Akad Med Bialymst; 2004; 49 Suppl 1():242-3. PubMed ID: 15638437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]